Market Place
Sourcing Support
India`s Hetero Targets Annual Sales of 1.5 mln Semaglutide Pens
17 Apr 2026 //
REUTERS
MS Pharma Group Inks Exclusive Biosimilars Deal With Hetero
26 Jan 2026 //
PR NEWSWIRE
Hyderabad Police Bust $250M Cyber Racket Targeting Hetero Group
20 Nov 2025 //
ECONOMICTIMES
6 pharma companies sign MoUs with Telangana for Pharma City
23 Nov 2024 //
BUSINESS STD
Hetero to invest Rs 1,000 crore in AP over two years to expand pharma business
04 Mar 2023 //
ECONOMIC TIMES
Hetero’s ‘NIRMACOM’ gets WHO Prequalification for COVID-19 treatment
26 Dec 2022 //
EXPRESSPHARMA
Hetero gets CDSCO nod to make & sell Sputnik Light vaccine in India
21 Mar 2022 //
ECONOMIC TIMES
Merck’s Anti-Covid Pill Shows Better Effectiveness In Indian Study
19 Feb 2022 //
FORBES
NPPA panel fixes retail price of Diclofenac transdermal patch
07 Feb 2022 //
MEDICALDIALOGUES
New toxic drug impurities detected in some heart pills in US
14 Oct 2021 //
ECONOMICTIMES
IT department detects Rs 550 crore in hidden income after raids
09 Oct 2021 //
ECONOMIC TIMES
India likely to allow export of Sputnik Light COVID shot this month - sources
24 Sep 2021 //
REUTERS
SEC seeks permission for Hetero to start manufacturing Russian Sputnik V vaccine
21 Sep 2021 //
PHARMABIZ
Hetero gets emergency use nod to make Roche’s COVID-19 drug
07 Sep 2021 //
EXPRESSPHARMA
India`s Hetero seeks emergency use nod for Merck`s COVID-19 drug
09 Jul 2021 //
REUTERS
Hetero Biopharma gets nod for Sputnik phase-3 trials
01 Jun 2021 //
ECONOMIC TIMES
Hetero recalls a batch of its remdesivir brand Covifor after side effects
04 May 2021 //
BUSINESS STANDARD
Hetero gets SEC approval for phase 3 trials of Sputnik V
30 Apr 2021 //
INDIATIMES
Hetero enters into voluntary licensing pact with MSD to manufacture
26 Apr 2021 //
PHARMABIZ
GSK sells off $155M Zantac plant India to Hetero Labs for fraction of its cost
01 Apr 2021 //
FIERCE PHARMA
Hetero Healthcare plans a slew of PPE products
26 Dec 2020 //
THEHINDUBUSINESSLINE
RDIF AND HETERO AGREE TO PRODUCE OVER 100 MILLION DOSES
30 Nov 2020 //
SPUTNIKVACCINE
Russia`s Sputnik V COVID-19 to be produced in India; RDIF and Hetero agree
26 Nov 2020 //
MONEYCONTROL
Six Indian drug companies to set up a large pharma cluster in Mexico
12 Oct 2020 //
ECONOMICTIMES
After tablets, Hetero working on antiviral medicine Favipiravir injections
08 Oct 2020 //
ECONOMICTIMES
Hetero launches pack of generic Covid-19 drug favipiravir at Rs 2,640
25 Sep 2020 //
BUSINESS-STANDARD
Hetero Labs gets Gujarat FDCA nod to MFG remdesivir injection through loan
11 Aug 2020 //
PHARMABIZ
Maharashtra gets 90,0000 remdesivir injections as manufacturers ramp up
30 Jul 2020 //
PHARMABIZ
Hetero announces the launch of ‘Favivir’ (Favipiravir 200 mg) in India
29 Jul 2020 //
PRESS RELEASE
Hetero launches Favivir to treat mild to moderate Covid-19
28 Jul 2020 //
EXPRESSPHARMA
Hetero starts supply of 60,000 vials of generic Remdesvir treatment of Covid-19
15 Jul 2020 //
ECONOMICTIMES
Hetero starts supply of 60,000 vials of generic Remdesvir for treatment
14 Jul 2020 //
ECONOMICTIMES
India`s Sovereign Pharma dispatches first batch of remdesivir to Cipla
07 Jul 2020 //
REUTERS
Hetero facilitates COVID-19 patients to access their remdesivir version
06 Jul 2020 //
MONEYCONTROL
Pharma major Mylan gets go-ahead to remdesivir for `restricted emergency use`
02 Jul 2020 //
ECONOMICTIMES
India poised to ramp up remdesivir production as Mylan & Jubilant Life Sciences
02 Jul 2020 //
PHARMABIZ
Mylan gets approval to make and market remdesivir
02 Jul 2020 //
EXPRESSPHARMA
Gujarat FDCA issues test license to Hetero to manufacture lyophilized injection
30 Jun 2020 //
PHARMABIZ
Hetero, Cipla get DCGI nod to Mfg remdesivir to treat COVID-19 patients in India
23 Jun 2020 //
BUSINESSTODAY
Hetero gets DCGI nod to launch Remdesivir for Covid-19 treatment
22 Jun 2020 //
ECONOMICTIMES
India gives Hetero Labs and Cipla approval to make Gilead`s COVID-19 drug
21 Jun 2020 //
REUTERS
Zydus Cadila signs licensing pact with Gilead for covid-19 drug remdesivir
13 Jun 2020 //
LIVEMINT
Cipla and Hetero seek clinical trial waiver for Remdesivir
22 May 2020 //
ECONOMICTIMES
Gilead ties up with generic drugmakers for COVID-19 drug supply
13 May 2020 //
REUTERS
FDA investigators discover key Strides Pharma quality records in shredding room
18 Jul 2019 //
FIERCE PHARMA
EMA Urges Pioglitazone Manufacturers to Check for Nitrosamine Impurities
26 Apr 2019 //
RAPS
FDA finds new cancer-causing impurity in blood pressure pills
02 Mar 2019 //
CNBC
Hetero Labs Limited acquires Tarbis Farma in Spain
03 Jan 2019 //
ECONOMIC TIMES
EMA recommends refusal of authorisation for Paclitaxel Hetero
19 Oct 2018 //
EMA
China vaccine fine, Lantus biosim and more—FiercePharmaAsia
19 Oct 2018 //
FIERCE PHARMA
India`s Hetero pulls heart drug from U.S. amid cancer risk probes
11 Aug 2018 //
ECONOMIC TIMES
Red Flags Raised at Chinese Heart Drug Maker Year Before Recall
10 Aug 2018 //
BLOOMERG
CCI penalises Glenmark Pharma, other entities for unfair business practices
14 Jul 2018 //
ECONOMIC TIMES
Hetero launches HumiraTM biosimilar in India
03 Jan 2018 //
ECONOMIC TIMES
Hetero launches FDC combination of key HIV drugs
14 Nov 2017 //
ECONOMIC TIMES
Hetero to supply swine flu drug to Gujarat govt
15 Aug 2017 //
PHARMABIZ
Granules, Hetero in patent battle with Takeda Pharma
15 Aug 2017 //
THE HINDU BUSINESS LINE
Hetero Drugs exploring in biosimlars; to launch more products soon
08 Feb 2017 //
PHARMABIZ
USFDA notice to Hetero over conditions at Telangana unit
23 Jan 2017 //
ECONOMIC TIMES
